期刊文献+

小剂量尿激酶对不稳定型心绞痛患者内皮素及纤溶酶原活性的影响 被引量:5

The effects of low dose of urokinase on endothelin and activities of endothelial tissue plasminogen in patients with unstable angina pectoris
原文传递
导出
摘要 目的:评价小剂量尿激酶对不稳定型心绞痛患者内皮源性血管活性物质内皮素 1、组织型纤溶酶原活性的影响,以探讨小剂量尿激酶治疗心绞痛的机制。方法:选择80例心电图负荷试验阳性、动态心电图出现缺血性改变的不稳定型心绞痛患者,静脉应用小剂量尿激酶3 d,于治疗前后分别测定内皮素 1、组织型纤溶酶原激活物及其抑制剂的变化。结果:与治疗前相比较,组织型纤溶酶原激活物升高,内皮素 1 及组织型纤溶酶原激活物抑制剂下降,其变化均具有显著性。结论:小剂量尿激酶可明显调节不稳定型心绞痛患者的内皮源性血管活性物质如内皮素 1、组织型纤溶酶原激活物及其抑制剂的活性。 Objective:To evaluate the effects of low dose of urokinase on endothelin and activities of endothelial tissue plasminogen in patients with unstable angina pectoris.Method:Eighty patients of unstable angina pectoris were studied. Their stress tests were abnormal and there were ischemic changes in Holter. Urokinase was used for 3 days through vein injections.Before and after urokinase treatments, endothelin-1, plasma tissue plasminogen activator and inhibitor-1 were determined. Result:Compared with pretreatments, after treatments, the activities of tissue plasminogen activator increased. Endothelin-1 and the inhibitor-1 decreased. The changes are significant. Conclusion:Low dose of urokinase can regulate the endothelial vasoactive substances in patients with unstable angina pectoris .The common substances include endothelin-1、plasma tissue plasminogen activator and inhibitor-1.So unstable angina pectoris can be treated by urokinase effectively.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第2期90-92,共3页 Journal of Clinical Cardiology
关键词 心绞痛 不稳定型 内皮素 纤溶酶原活性 尿激酶 Angina pectoris, unstable Endothelin Plasminogen activities Urokinase
  • 相关文献

参考文献8

  • 1胡大一,顼志敏.不稳定性心绞痛溶栓治疗的评价[J].中华心血管病杂志,1996,24(3):165-166. 被引量:89
  • 2桑培昌.小剂量尿激酶治疗不稳定型心绞痛的临床观察[J].临床荟萃,2002,17(1):33-33. 被引量:2
  • 3国家九五攻关课题组不稳定心绞痛UK溶栓治疗的临床疗效-多中心随机对照研究[J].中华心血管病杂志,1999,27(5):342-344.
  • 4吴志峰,高明乐,姜毅,王军,郭素华.小剂量尿激酶治疗不稳定性心绞痛的临床分析[J].中国心血管杂志,2002,7(2):129-131. 被引量:6
  • 5The TIMI ⅢB Investigators . Effects of tissue plasminogen activator and a comparison of early invasive and conservation strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI ⅢB trial. Circulation,1994,89:1545-1556.
  • 6Romeo F, Rosano G M C, Marhu S, et al. Effectiveness of prolonged low does, Recombinant tissue-type plasminogen activator for refractory unstable angina. JACC,1995,25:1295-1296.
  • 7Chen J L. Randomized clinical trial of urokinase versus heparin in unstable angina. J Thrombo Thrombolysis, 1999, 8: 223-226.
  • 8Fuster V. 50th anniversary historical article. Acute coronary syndromes,:the degree and morphology of coronary stenoses. J Am Coll Cardiol,2000,35(5 Suppl B):52B-54B.

二级参考文献7

共引文献94

同被引文献16

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部